| SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2 TM Clausen, DR Sandoval, CB Spliid, J Pihl, HR Perrett, CD Painter, ... Cell 183 (4), 1043-1057. e15, 2020 | 1029 | 2020 |
| Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques NB Mercado, R Zahn, F Wegmann, C Loos, A Chandrashekar, J Yu, J Liu, ... Nature 586 (7830), 583-588, 2020 | 958 | 2020 |
| Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19 N Kaneko, HH Kuo, J Boucau, JR Farmer, H Allard-Chamard, ... Cell 183 (1), 143-157. e13, 2020 | 686 | 2020 |
| Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients AS Iyer, FK Jones, A Nodoushani, M Kelly, M Becker, D Slater, R Mills, ... Science immunology 5 (52), eabe0367, 2020 | 676 | 2020 |
| COVID-19-neutralizing antibodies predict disease severity and survival WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang, TE Miller, J Feldman, ... Cell 184 (2), 476-488. e11, 2021 | 655 | 2021 |
| Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic AG Edlow, JZ Li, YC Ai-ris, C Atyeo, KE James, AA Boatin, KJ Gray, ... JAMA network open 3 (12), e2030455-e2030455, 2020 | 384 | 2020 |
| Distinct early serological signatures track with SARS-CoV-2 survival C Atyeo, S Fischinger, T Zohar, MD Slein, J Burke, C Loos, DJ McCulloch, ... Immunity 53 (3), 524-532. e4, 2020 | 358 | 2020 |
| CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 R Amraei, W Yin, MA Napoleon, EL Suder, J Berrigan, Q Zhao, J Olejnik, ... ACS Central Science 7 (7), 1156-1165, 2021 | 316 | 2021 |
| Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters LH Tostanoski, F Wegmann, AJ Martinot, C Loos, K McMahan, ... Nature medicine 26 (11), 1694-1700, 2020 | 302 | 2020 |
| Compromised humoral functional evolution tracks with SARS-CoV-2 mortality T Zohar, C Loos, S Fischinger, C Atyeo, C Wang, MD Slein, J Burke, J Yu, ... Cell 183 (6), 1508-1519. e12, 2020 | 285 | 2020 |
| In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies D Li, RJ Edwards, K Manne, DR Martinez, A Schäfer, SM Alam, K Wiehe, ... Cell 184 (16), 4203-4219. e32, 2021 | 234 | 2021 |
| Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production Y Chen, A Zuiani, S Fischinger, J Mullur, C Atyeo, M Travers, FJN Lelis, ... Cell 183 (6), 1496-1507. e16, 2020 | 193 | 2020 |
| Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital TE Miller, WFG Beltran, AZ Bard, T Gogakos, MN Anahtar, MG Astudillo, ... The FASEB Journal 34 (10), 13877, 2020 | 149 | 2020 |
| Antibodies to a conserved influenza head interface epitope protect by an IgG subtype-dependent mechanism A Watanabe, KR McCarthy, M Kuraoka, AG Schmidt, Y Adachi, T Onodera, ... Cell 177 (5), 1124-1135. e16, 2019 | 148 | 2019 |
| Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19 M Norman, T Gilboa, AF Ogata, AM Maley, L Cohen, EL Busch, ... Nature biomedical engineering 4 (12), 1180-1187, 2020 | 144 | 2020 |
| SARS-CoV-2-specific ELISA development V Roy, S Fischinger, C Atyeo, M Slein, C Loos, A Balazs, C Luedemann, ... Journal of immunological methods 484, 112832, 2020 | 85 | 2020 |
| Rapid generation of potent antibodies by autonomous hypermutation in yeast A Wellner, C McMahon, MSA Gilman, JR Clements, S Clark, KM Nguyen, ... Nature chemical biology 17 (10), 1057-1064, 2021 | 80 | 2021 |
| High seroprevalence of anti-SARS-CoV-2 antibodies in Chelsea, Massachusetts V Naranbhai, CC Chang, WFG Beltran, TE Miller, MG Astudillo, ... The Journal of infectious diseases 222 (12), 1955-1959, 2020 | 79 | 2020 |
| An aluminum hydroxide: CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice E Nanishi, F Borriello, TR O’Meara, ME McGrath, Y Saito, RE Haupt, ... Science translational medicine 14 (629), eabj5305, 2021 | 70 | 2021 |
| The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates D Li, RJ Edwards, K Manne, DR Martinez, A Schäfer, SM Alam, K Wiehe, ... BioRxiv, 2020.12. 31.424729, 2021 | 59 | 2021 |
